Expression of fibrosis‐related genes in liver allografts: Association with histology and long‐term outcome after pediatric liver transplantation-Reference-Cited by-同舟云学术

Expression of fibrosis‐related genes in liver allografts: Association with histology and long‐term outcome after pediatric liver transplantation

Published:2021-06-27 Issue:8 Volume:35 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Voutilainen Silja H.¹^ORCID,Kosola Silja K.²,Lohi Jouko³,Jahnukainen Timo⁴,Pakarinen Mikko P.¹,Jalanko Hannu⁴

Affiliation:

1. Pediatric Surgery and Pediatric Transplantation Surgery Pediatric Liver and Gut Research Group New Children's HospitalHelsinki University, Hospital and University of Helsinki Helsinki Finland

2. Pediatric Research Center New Children's HospitalHelsinki University Hospital, and University of Helsinki Helsinki Finland

3. Department of Pathology Helsinki University Hospital and University of Helsinki Helsinki Finland

4. Department of Pediatric Nephrology and Transplantation New Children's HospitalHelsinki University Hospital and University of Helsinki Helsinki Finland

Funder

Helsingin ja Uudenmaan Sairaanhoitopiiri

Lastentautien Tutkimussäätiö

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14373

Reference56 articles.

1. Long-Term Patient Outcome and Quality of Life After Liver Transplantation

2. Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments

3. Current views on rejection pathology in liver transplantation

4. Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts

5. Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered fibrotic liver-targeted truncated transforming growth factor β receptor type II variant for superior anti-liver fibrosis therapy;Archives of Pharmacal Research;2023-03

2. Integrins: Key Targets in Tissue Fibrosis and Tumor Stroma;Integrins in Health and Disease;2023